>
WEBINAR

Regulatory AMA: EU MDR Transition Period Extension

Replay

After the EU MDR transition period was recently extended, it quickly became clear that the extension doesn't mean that all medtech companies can delay compliance for all devices. Which companies will benefit the most and which devices will need to comply with MDR more quickly? How will the "sell-off" period removal affect the industry and what happens now that the MDR transition period extends beyond the expected start of mandated EUDAMED compliance? Our expert panel, including Rimsys Founder and President, James Gianoutsos; Bruce McKean, Director of Regulatory with Rimsys; and Adam Price, Director of Product with Rimsys answered a lot of questions!

More infoWatch ReplayGet the ebookGet the briefGet the case studyGet the data sheetGet the webinarGet the video
Regulatory AMA: EU MDR Transition Period Extension

Get the ebook

Get the case study

Get the webinar

Watch the replay!

Get the video

Get the data sheet

Thank you! Here's a link to your resource. We've also sent a copy to your inbox. Enjoy!
Thank you! We've sent you you details about accessing this event. If you do not receive an email in the next few minutes, please check your spam folder. Enjoy!
Download
Here's some additional content you may find helpful
A primer on medical device classification
A primer on medical device classification
Quick reference guide - global medical device UDI requirements and timelines
Quick reference guide - global medical device UDI requirements and timelines
5 ways a RIM system can accelerate time-to-market for MedTech companies
5 ways a RIM system can accelerate time-to-market for MedTech companies
Here's your video, enjoy!
Check out these additional resources
5 ways a RIM system can accelerate time-to-market for MedTech companies
5 ways a RIM system can accelerate time-to-market for MedTech companies
Quick reference guide - global medical device UDI requirements and timelines
Quick reference guide - global medical device UDI requirements and timelines
 Introducing Rimsys Intel: A Free, Centralized Global Regulatory Intelligence Hub for Medtech
Introducing Rimsys Intel: A Free, Centralized Global Regulatory Intelligence Hub for Medtech
Oops! Something went wrong while submitting the form